secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Acquisition Corp./Cayman Islands (VACH)
CIK:        0002006815
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001829126-26-001748
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VERAXA shareholders approve merger with Voyager SPAC; CHF 223,400 capital increase
--------------------------------------------------------------------------------

- Shareholders approved absorption merger of VERAXA into Veraxa Biotech Holding AG; combined entity to rename to Veraxa Biotech AG.
- Approved ordinary capital increase of CHF 223,400 for shares to be issued to Voyager shareholders.
- Christoph Antz remains CEO; closing subject to Voyager shareholder vote; Nasdaq ticker expected to be VRXA.
- Business combination originally announced April 22, 2025; proxy statement/prospectus filed Feb 19, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006815/000182912626001748/0001829126-26-001748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006815/000182912626001748/voyageracq_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-001748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer